Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04726514 · ClinicalTrials.gov registry record · NA
SleepFlexTM Treatment of Obstructive Sleep Apnea
A NA study of Obstructive Sleep Apnea, sponsored by Berendo Scientific.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT04726514: Completed NA study of Obstructive Sleep Apnea, sponsored by Berendo Scientific.
NCT04726514 is a NA study of Obstructive Sleep Apnea that has completed, run by Berendo Scientific. The registered enrollment target is 10 participants, below the 222-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04726514, a NA study of Obstructive Sleep Apnea, has completed, sponsored by Berendo Scientific.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of the SleepFlex program for treatment of mild to moderate OSA
Primary Outcome
Number of participants with absence of serious adverse events related to the SleepFlex system.
Conditions Studied
Interventions
- DEVICE SleepFlex
Study Locations (1)
California
- Tower Sleep Medicine - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-07-20 |
| Est. Completion | 2022-05-31 |
| Phase | NA |
What the finished NCT04726514 record still lists
NCT04726514 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 222-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which SleepFlex is the first listed.
NCT04726514 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04726514 about?
NCT04726514 is a clinical study titled "SleepFlexTM Treatment of Obstructive Sleep Apnea". The purpose of this study is to evaluate the safety and effectiveness of the SleepFlex program for treatment of mild to moderate OSA
What is the current status of trial NCT04726514?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-07-20. Estimated completion is 2022-05-31.
What conditions does trial NCT04726514 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea.
What interventions are being tested in trial NCT04726514?
The interventions under investigation include: SleepFlex (DEVICE).
Who is sponsoring clinical trial NCT04726514?
This trial is sponsored by Berendo Scientific, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04726514 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04726514's enrollment target sits among peer trials
10 152nd of 155 higher than 2 of 155 other Obstructive Sleep Apnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
-
Mandibular Advancement Device and Changes in Nocturia
RECRUITING · NA
-
Severe Label Expansion for EVO Products Trial
RECRUITING · NA
-
App-Based Optimization of Long-Term CPAP Adherence and Quality of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI